News & Events

• January 25, 2023
  

  C-Path Receives Letter of Support from EMA on Duchenne Muscular Dystrophy Clinical Trial Simulation Platform

  C-Path today announced that the European Medicines Agency (EMA) has issued a letter of support for the Duchenne Regulatory Science Consortium’s (D-RSC) Model-based Clinical Trial Simulation Platform for Duchenne Muscular Dystrophy (DMD).

• January 23, 2023
  

  C-Path and Mobilise-D Collaborate to Improve Impact on the Organizations’ Common Goals

      Critical Path Institute is pleased to announce the recent collaboration agreement between C-Path and Mobilise-D. By combining C-Path’s unique global regulatory expertise and Mobilise-D’s focus on digital assessment of mobility, this mutually beneficial partnership aims to accelerate and improve the impact of these important initiatives that share common goals. The Critical Path for...
• December 20, 2022
  

  C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System

  The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for allograft loss.

• December 20, 2022
  

  C-Path Receives Letter of Support from EMA for Parkinson’s Disease Clinical Trial Simulation Platform

  C-Path today announced that the European Medicines Agency (EMA) has issued a letter of support for the Critical Path for Parkinson’s (CPP) Consortium’s Model-based Clinical Trial Simulation Platform to Optimize Design of Efficacy Evaluation Studies in Parkinson’s Disease (PD).

• December 16, 2022
  

  eCOA Consortium and PRO Consortium Announce Publication of Two Open Access Articles

  C-Path’s eCOA Consortium and PRO Consortium are pleased to announce the publication of two open access articles in the Journal of Patient-Reported Outcomes, titled “Comparability of a Provisioned Device Versus Bring Your Own Device for Completion of Patient-Reported Outcome Measures by Participants with Chronic Obstructive Pulmonary Disease: Qualitative Interview Findings” and “Comparability of a Provisioned Device Versus Bring Your Own Device for...